Xu‐Hong Wei
- Physiology top 2%
- Pain Mechanisms and Treatments 36
- Adenosine and Purinergic Signaling 5
-
- Neuroscience and Neuropharmacology Research 9
- Neuropeptides and Animal Physiology 6
- Neurology top 5%
- Botulinum Toxin and Related Neurological Disorders 8
- Behavioral Neuroscience top 5%
- Biological Psychiatry top 5%
-
- Pharmacological Effects of Natural Compounds 6
- Musculoskeletal pain and rehabilitation 5
-
- Ion channel regulation and function 5
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xu‐Hong Wei
40 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 91
- Physiology 1.2k
- Cellular and Molecular Neuroscience 657
- Neurology 252
- Behavioral Neuroscience 93
- Biological Psychiatry 65
Countries citing papers authored by Xu‐Hong Wei
This map shows the geographic impact of Xu‐Hong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu‐Hong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu‐Hong Wei more than expected).
Fields of papers citing papers by Xu‐Hong Wei
This network shows the impact of papers produced by Xu‐Hong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu‐Hong Wei. The network helps show where Xu‐Hong Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xu‐Hong Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 15 | |
| 5 | 2022 | 6 | |
| 6 | 2020 | 7 | |
| 7 | 2019 | 8 | |
| 8 | 2018 | 22 | |
| 9 | 2016 | 21 | |
| 10 | 2016 | 14 | |
| 11 | 2014 | 54 | |
| 12 | 2013 | 12 | |
| 13 | 2013 | 92 | |
| 14 | 2013 | 79 | |
| 15 | 2012 | 33 | |
| 16 | 2012 | 83 | |
| 17 | 2011 | 200 | |
| 18 | 2011 | 67 | |
| 19 | 2010 | 35 | |
| 20 | 2010 | 144 |
About Xu‐Hong Wei
Xu‐Hong Wei is a scholar working on Physiology, Physiology and Cellular and Molecular Neuroscience, having authored 42 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (36 papers), Neuroscience and Neuropharmacology Research (9 papers), Botulinum Toxin and Related Neurological Disorders (8 papers), Pharmacological Effects of Natural Compounds (6 papers), Neuropeptides and Animal Physiology (6 papers), Musculoskeletal pain and rehabilitation (5 papers), Adenosine and Purinergic Signaling (5 papers) and Ion channel regulation and function (5 papers). The work is most often cited by research in Physiology (1.2k citations), Cellular and Molecular Neuroscience (657 citations) and Neurology (252 citations). Xu‐Hong Wei has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xian‐Guo Liu, Wen‐Jun Xin, Ying Zang, Yongyong Li, Rui‐Ping Pang, Li‐Jun Zhou, Changyou Wu, Ji‐Tian Xu, Wenjie Ren and Zhihai Qin. Their work appears in journals such as Experimental Neurology, Pain, Anesthesiology, Brain Behavior and Immunity and Neurochemical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.